Side Letter: CalSTRS bags 52%; PE competes on comp; SEC alum talks GP-led reg risks

CalSTRS has reported an eye-watering PE return as it pivots towards co-investing. Plus: What PE's biggest firms are paying their junior staff and regulatory risks to be aware of when conducting a GP-focused secondaries deal. Here's today's brief, for our valued subscribers only.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this